Yeh‐Hsing Lao
Papers
1
Total Citations
2
H-Index
1
About
Yeh-Hsing Lao is a pioneering researcher at the intersection of nanomedicine and gene editing, with a primary focus on developing CRISPR/Cas-based nanotheranostics for combating viral hepatitis and hepatocellular carcinoma. His most notable contribution is the comprehensive overview of nanoscale CRISPR/Cas systems as "smart enzymatic robots" capable of precisely targeting liver diseases, published in *Advanced Science* (2021). This work has garnered 2 citations and highlights his innovative approach to integrating nanotechnology with CRISPR platforms for both diagnostic and therapeutic applications. Lao’s research addresses critical challenges in viral hepatitis and liver cancer treatment, proposing advanced nanocarriers that enhance the delivery, stability, and specificity of CRISPR components. His work stands out for its forward-looking perspective on how nanotheranostics can revolutionize precision medicine, offering a blueprint for future clinical translations. As a key collaborator in multidisciplinary teams, Lao’s contributions are shaping the next generation of smart, programmable therapeutics, making him a notable figure in the rapidly evolving field of gene-editing nanomedicine.
Research Focus
Key Achievements
Top Papers
- 1